Curt I. Civin, M.D., FAAP, of Baltimore, who in 1984 invented a stem cell selection process that paved the way for more effective and less toxic cancer therapies, is the 1999 recipient of the Inventor of the Year Award from the Intellectual Property Owners Association, Washington, D.C.

He developed the CD34 stem cell monoclonal antibody, which binds to an antigen. He is the inventor or co-inventor of nine U.S. patents for biomedical inventions.

Dr. Civin is the King Fahd Professor of Oncology and Pediatrics, and director of the Division of Pediatric Oncology at Johns Hopkins Oncology Center, Baltimore. He is associate editor of the journal Stem Cells, has lectured worldwide, and is the author of two medical books and many articles.

This content is only available via PDF.
You do not currently have access to this content.